References
- Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89(5):771–82. doi:https://doi.org/10.1590/abd1806-4841.20143063.
- Lee AY. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28(6):648–60. doi:https://doi.org/10.1111/pcmr.12404.
- Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Women Dermatol. 2017;3(1):11–20. doi:https://doi.org/10.1016/j.ijwd.2017.01.004.
- Balakrishna C, Payili N, Yennam S, Uma Devi P, Behera M. 2015. Synthesis of new kojic acid based unnatural α-amino acid derivatives. Bioorg Med Chem Lett. 25(21):4753–56. doi:https://doi.org/10.1016/j.bmcl.2015.07.099.
- Yenni SW. 2018. Comparison of the use of 5% methimazole cream with 4% kojic acid in melasma treatment. Turk J Dermatol. 12(4):167–71. doi:https://doi.org/10.4274/tdd.3640.
- Deo KS, Dash KN, Sharma YK, Virmani NC, Oberai C. 2013. Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety. Indian J Dermatol. 58(4):281–85. doi:https://doi.org/10.4103/0019-5154.113940.
- Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. 2013. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 58(2):157. doi:https://doi.org/10.4103/0019-5154.108070.
- Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20(5):308–13. doi:https://doi.org/10.1111/j.1529-8019.2007.00144.x.
- Erlendsson AM, Anderson RR, Manstein D, Waibel JS. Developing technology: ablative fractional lasers enhance topical drug delivery. Dermatol Surg. 2014;40(Supplement 12):142–46. doi:https://doi.org/10.1097/DSS.0000000000000207.
- Manaloto RM, Erbium: AT.YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25(2):121–23. doi:https://doi.org/10.1046/j.1524-4725.1999.08103.x.
- Attwa E, Khater M, Assaf M, Haleem MA.Melasma treatment using an erbium: YAG laser: a clinical, immunohistochemical, and ultrastructural study. Int J Dermatol. 2015;54(2):235–44. doi:https://doi.org/10.1111/ijd.12477.
- Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S, Chen TM. 2009. Treatment of melasma using variable square pulse Er: YAGlaser resurfacing. Dermatol Surg. 35(3):475–82. doi:https://doi.org/10.1111/j.1524-4725.2009.01066.x.
- Manuskiatti W, Iamphonrat T, Wanitphakdeedecha R, Eimpunth S. 2013. Comparison of fractional erbium-doped yttrium aluminum garnet and carbon dioxide lasers in resurfacing of atrophic acne scars in Asians. Dermatol Surg. 39(1 Pt 1):111–20. doi:https://doi.org/10.1111/dsu.12030.
- Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR.Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426–38. doi:https://doi.org/10.1002/lsm.20048.
- Trelles MA, Velez M, Gold MH.The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study. J Drugs Dermatol. 2010;9(4):315–22.
- Tawfic SO, Abdel Halim DM, Albarbary A, Abdelhady M. Assessment of combined fractional CO2 and tranexamic acid in melasma treatment. Lasers Surg Med. 2019 Jan;51(1):27–33. doi:https://doi.org/10.1002/lsm.23032.
- Haedersdal M, Erlendsson AM, Paasch U, Anderson RR. 2016. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol. 74(5):981–1004. doi:https://doi.org/10.1016/j.jaad.2015.12.008.
- Erlendsson AM, Anderson RR, Manstein D, Waibel JS. Developing technology: ablative fractional lasers enhance topical drug delivery. Dermatol Surg. 2014;40(Supplement 12):142–46.
- Badawi AM, Osman M. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol. 2018;11:13–20. doi:https://doi.org/10.2147/CCID.S147413.
- Namazi N, Hesami A, Ketabi Y. The split-face comparison of the combined Er-YAG laser and hydroquinone 4% with hydroquinone 4% alone in the treatment of melasma in Iranian patients. A prospective, interventional case study. J Lasers Med Sci. 2020;11(1):70–73. doi:https://doi.org/10.15171/jlms.2020.12.
- Saeedi M, Eslamifar M, Khezri K. Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 2019;110:582–93. doi:https://doi.org/10.1016/j.biopha.2018.12.006.
- Attwa E, Khater M, Assaf M, Abdel Haleem M.Melasma treatment using an erbium: yAGlaser: a clinical, immunohistochemical, and ultrastructural study. Int J Dermatol. 2015;54(2):235–44.